BiotechTube
Home/IsomAb/Dr Gary Burgess
DG

Dr Gary Burgess

Chief Medical Officer

IsomAb

Therapeutic Areas

Cardiovascular

IsomAb Pipeline

DrugIndicationPhase
ISM-001Chronic Stable Angina (Coronary Artery Disease)Pre-clinical

Leadership Team at IsomAb

DP
Dr Philip Brainin
Chief Executive Officer
JA
Julian Attfield
Chief Financial Officer/Company Secretary
PD
Professor David Bates
Chief Scientific Officer
View full IsomAb profile